WB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WB is not a good buy right now for an impatient trader. Price is breaking below near-term support with worsening momentum (negative, expanding MACD histogram). While options positioning looks bullish and implied volatility is low (which can help reward/risk for directional bets), there are no Intellectia buy signals and no near-term catalysts/news to force a reversal immediately. I would wait for a reclaim of ~10.56–10.80 (S1/pivot) or a clear bounce off ~10.41 (S2) before treating it as a buy.
Trend/Momentum: Short-term momentum is bearish: MACD histogram is -0.0323 and negatively expanding (selling pressure increasing). RSI(6)=35.5 is weak (near oversold but not a clear reversal signal). Structure: Moving averages are still bullish (SMA_5 > SMA_20 > SMA_200), suggesting the bigger-picture trend hasn’t fully broken, but the current tape is pulling back. Levels: Pivot=10.796. Resistance: 11.037 (R1) then 11.185 (R2). Support: 10.555 (S1) and 10.407 (S2). With price ~10.48, WB is trading below S1, so the immediate setup is ‘support break’ risk unless it quickly reclaims 10.56+. Pattern-based odds: Similar-pattern stats imply modest upside probabilities (next day +0.81%, next week +3.13%, next month +12.1%), but those are not strong enough to override the current negative momentum for an immediate entry.
Intellectia Proprietary Trading Signals
Longer-term MA stack (SMA_5>SMA_20>SMA_
suggests the broader trend may still be constructive if support holds. Q3 FY2025 showed strong YoY net income (+69.33%) and EPS (+67.35%) growth.
No news/events in the past week—no obvious catalyst to reverse the current pullback quickly. Momentum is deteriorating (MACD negative and expanding) and price is currently below S1 (10.555), raising risk of a flush toward S2 (10.407). Q3 FY2025 revenue declined (-4.77% YoY) and gross margin fell (75.99, down -5.14% YoY), suggesting core growth/quality pressure despite higher net income/EPS.
Latest reported quarter: 2025/Q3. Revenue fell to 442.3M (-4.77% YoY), indicating top-line contraction. Profitability metrics were mixed: Net income rose to 221.1M (+69.33% YoY) and EPS increased to 0.82 (+67.35% YoY), but gross margin declined to 75.99 (down -5.14% YoY). Overall: earnings improved sharply, but the growth trend is not clean because revenue and margin weakened.
No analyst rating/price target change data was provided, so the recent Wall Street trend cannot be confirmed from this dataset. Practical read from available data: fundamentals are mixed (revenue/margin down, earnings up), which typically leads to a split pro/con view—bull case hinges on profitability and potential re-rating from low expectations; bear case focuses on slowing top-line and margin compression. Influential/political trading: No recent congress trading data available; hedge fund and insider trends are both reported as neutral.
